prostate cancer index | prostate cancer | prostatectomy | radiation | hormone | cryosurgery | hifu | wait & see | alternative treatment | diet | articles | contact |

Archive for the ‘watchful waiting’ Category

Active surveillance must be combined with vigorous exercise

Thursday, June 23rd, 2011 Posted in watchful waiting | No Comments »

A new Bay Area research suggests that instead of surgery or radiation, “active surveillance” combined with certain exercise may actually help prostate cancer patients live a long, healthier life. The study leader said that vigorous exercise, such as a brisk walk, can make ...

Study: watchful waiting is a better option than radiation

Wednesday, June 8th, 2011 Posted in radiation therapy, watchful waiting | No Comments »

A new research at Tufts University Medical Center finds there's too little evidence to say definitively whether treating early, localized prostate cancer with radiation is a better option than "watchful waiting". In a study funded by the Agency for Healthcare Research ...

Implication in selecting candidates for active surveillance

Tuesday, June 7th, 2011 Posted in watchful waiting | No Comments »

A new study targeted the association of urinary PCA3 score with prostatectomy tumor volume and other clinical and pathological features. Researchers concluded the PCA3 score appears to stratify men based on prostatectomy tumor volume and Gleason score, and may have clinical applicability ...

Study: robotic prostatectomy is a wonderful option for patients

Saturday, May 28th, 2011 Posted in prostatectomy, watchful waiting | No Comments »

A new prostate cancer study comparing surgical treatment to "watchful waiting" revealed important findings for patients newly diagnosed with prostate cancer and currently debating their treatment options. Two of the most commonly offered clinical options for early prostate cancer treatment today ...

Prostate cancer surgery helps younger men

Friday, May 6th, 2011 Posted in prostatectomy, watchful waiting | No Comments »

Statistics say the Scandinavian men had more advanced prostate cancer than most American men. Then, a recent study targeted to compare death rates in Scandinavian men that opted for surgery (prostattectomy) or watchful waiting. The study looked at men who had growths ...

Active surveillance may be a better option for slow-growing prostate cancer

Wednesday, April 20th, 2011 Posted in prostatectomy, watchful waiting | No Comments »

According to a long-running Johns Hopkins study of 769 men with prostate cancer, men with low-grade prostate cancer can opt out of surgery without much risk of death. Study team suggests active surveillance may be a better option. Published online in ...

Repeat biopsies may be important for patients on active surveillance

Thursday, March 24th, 2011 Posted in watchful waiting | No Comments »

A new report at the University of California, San Francisco, has emphasized the potential importance of repeat biopsies in patients being managed with active surveillance (AS). The study concludes that there is little change in the PSA levels during the first 2 ...

Active surveillance or immediate treatment

Wednesday, March 16th, 2011 Posted in watchful waiting | No Comments »

Active surveillance, also referred to as watchful waiting, is a viable option for many men with low-risk prostate cancer although the concept continues to cause distress and confusion for many men, especially when they read about the controversies associated with ...

Acceptance/outcomes data of AS regardless of age

Wednesday, March 2nd, 2011 Posted in watchful waiting | No Comments »

A recent report from the Cleveland Clinic provides rigorous data on the acceptability and outcomes of active surveillance (AS) as a management strategy for men diagnosed with low-risk prostate cancer — regardless of their age at the time of diagnosis. The report authors ...

Avodart could make ‘watchful waiting’ appealing

Friday, February 18th, 2011 Posted in watchful waiting | No Comments »

A new study at University of Michigan suggests a way to help men with early, low-risk prostate cancer avoid being overtreated for a disease that in most cases will never threaten their lives. Researchers found that a drug can slow the ...